S
ystemic lupus erythematosus (SLE) is an autoimmune disease characterized by the loss of tolerance to self-nuclear antigens, in which altered B-cell signaling shows an essential role. 1 The clonal expansion and antigen-based affinity maturation of B cells primarily occurs at germinal centers (GCs). 2 Significantly, recent studies have demonstrated that the robust activity of GCs and the breach of tolerance to self-nuclear antigens are associated with the pathogenesis of SLE. [3] [4] [5] Spontaneous GCs (Spt-GCs) can arise in the absence of purposeful immunizations or overt infection and are detected in mice strains with or without autoimmune phenotypes, as well as in human SLE. [3] [4] [5] However, the size and the somatic hypermutation frequency of Spt-GCs were shown to be augmented in autoimmune-prone mice, leading to the development of class-switched pathogenic antibodies that drive autoantibodymediated immune diseases. 5 These data suggest that robust Spt-GC is one of the major abnormal sites contributing to the pathogenesis of SLE. It is well accepted that to initiate successful GC formation, at least two signal inductions are needed: engagement with an antigen by naive B cells and the presentation of an antigen by the B cells to Tfh cells, which, in turn, form B-Tfh conjugations. 2 In this paper, the activation of Toll-like receptor 7 (TLR7) is proposed and discussed as the third signal for the robust generation of Spt-GC B cells in SLE.
TLR7 is an endosomal TLR that recognizes single-stranded RNA, leading to the activation of innate or adaptive immunity. It was reported that B-cellintrinsic TLR7 has a pivotal role in the development of SLE. 6 In fact, B-cellintrinsic TLR7 signaling is an essential factor for the formation and responses of Spt-GCs in both autoimmune and nonautoimmune conditions. 5, 6 For example, the formation of Spt-GC and the production of auto-antibodies can be driven by the activation of B-cell-intrinsic TLR7 in lupus models, 3 but lupus-prone Sle1b mice with a TLR7-KO genotype failed to form Spt-GC B cells. 6 Normal mice exposed to TLR7 agonists exhibited typical lupus features, including the expansion of GCs and the production of autoantibodies. 7 Moreover, murine B cells were induced to proliferate, and this was accompanied by an upregulated level of B-cell co-stimulatory factors, the switch of Ig classes and the secretion of immunoglobulins after TLR7 activation. 6, 8 All these studies suggest that TLR7 could drive the pathogenesis of SLE by regulating germinal centers (GCs) formation, while the molecular mechanism underlying this regulation is poorly defined.
Autoreactive B cells resulting from GCs that experience class-switch and somatic hypermutation (SHM), are ordinarily induced to death by negative selection. 1 However, the exclusion function of these autoreactive B cells in GCs is defective in both lupus mice 9 and human SLE. 4 Prolonged GC activity could lead to high-affinity antibodies through the extended SHM, but in return, the extended SHM also increases the chance of the appearance of selfreactive variants producing autoantibodies that finally escape the negative affinity selection. 2 The activation of TLR7 has been reported to enhance the persistence of GCs for several months in mice 10 and is involved in the biased selection of the autoreactive B-cell repertoire in lupus-like GCs. 9 In addition, lupus-prone mice deficient in TLR7 abrogated the production of an RNAspecific autoantibody. 5 Moreover, mice deficient in TLR7 signaling exhibit a significant reduction in the GC response upon an RNA virus challenge and have a relatively diminished dark zone, where extensive proliferation and SHM occurs, which ultimately leads to the decreased generation of high-affinity anti-viral antibodies. 3 The above results suggest that TLR7 may play a key role in the SHM and affinity selection in GC, which could contribute to the development of autoreactive B cells.
Cyclin D3 (CCND3) is a gene found in GC B cells that is necessary for the formation and expansion of GCs. 11, 12 It has been reported that the development of GCs was markedly impaired in CCND3 − / − mice, and this was accompanied by a significant number of GC B cells arrested at the G0 phase. 11 Dysregulated signaling of TLR7 or the B-cell receptor (BCR) and cytokines in B cells was reported to sufficiently initiate SptGCs responses. 1 Our earlier finding was that the TLR7, BCR and interferon (IFN)-α signaling pathways were simultaneously activated in the peripheral blood B cells of active SLE patients. 13 While our gene microarray results showed a significant up-regulation of CCND3 expression in B cells from patients with active SLE, our study demonstrated that TLR7 signaling, not BCR or IFN-α signaling, promoted the expression of CCND3 in mice B cells. 14 Furthermore, CCND3 was also significantly upregulated in GC B cells in a lupus mouse model induced by the TLR7 agonist imiquimod (IMQ). 14 More interestingly, the maturation of B-cell affinity within GC is deficient in CCND3 − / − mice, and affinity-matured IgGs were not produced. 12 Therefore, we speculate that the activation of TLR7 in B cells is indispensable for robust GC formation by upregulating the expression of CCND3, which is accompanied by a rapid cell cycle, a hyperextended SHM, disrupted affinity selection and a failed exclusion of autoreactive B cells.
Moreover, clinical testing showed that apoptotic cells accumulated in the GCs of the lymph nodes in SLE, which resulted in subsequent secondary necrosis due to inefficient clearance; 5 hence, the accumulated debris from dead cells became the main source of autoantigen immune complexes (ICs). In line with this, the chronic activation of TLR7 also dampens the cleaning efficiency of tingible body macrophages within GCs, which could also contribute to the pathogenesis of SLE. 3,15,16 More importantly, the highly apoptotic environment in the light zone of GCs, because of the consequences of affinity selection and defects in clearing apoptotic debris by tingible body macrophages in SLE, may trigger enhanced GC responses and autoimmunity. 3,15 Interestingly, our recent data showed an increase in cell death of the splenic macrophages from IMQ-induced lupus mice through TLR7-dependent autophagy. 17 These defects in the clearance of apoptotic debris within GCs may ultimately result in the BCRmediated internalization of nucleic acidcontaining debris and the stimulation of autoantibody production by disturbing TLR7-based negative affinity selection. In addition, those self-RNA-containing ICs may also activate the adjacent follicular B cells, leading to persistent GC activity. 1, 3 In summary, we propose that the activation of TLR7 as a third signal strongly influences the formation of Spt-GC by increasing the speed of B-cell proliferation, hyperextending the SHM and triggering the death of tingible body macrophages, which ultimately leads to the failed exclusion of autoreactive B cells (Figure 1) .
GCs are important for the acquisition of auto-reactivity in SLE. Targeting GCs has been and should continue to be a Figure 1 Proposed mechanisms of TLR7 involved in the dysregulation of germinal center B cells in SLE. After binding to antigens derived from apoptotic debris, B-cell receptors (BCRs) traffic ssRNA to the endosomal receptor TLR7, initiating B-cell activation in response to integrated BCR-dependent and TLR7-dependent signaling. Hence, the activation of TLR7 will increase the expression level of CCND3. The increased expression of CCND3 will promote B cells to proliferate vigorously to form enlarged and long-lasting germinal centers under the help of Tfh cells. After the SHM in the DZ, these GC B cells are shuttled to the LZ to go through affinity maturation selection, leading to high apoptosis. The accumulated debris may stimulate autoantibody production through the internalization of nucleic acid-containing debris and influence the censorship in the LZ. On the other hand, they may also further activate adjacent follicular B cells, leading to persistent GC activity. In summary, the formation of robust GCs can be induced by the excessive TLR7 signal in SLE, accompanied by an increase in the levels of autoreactive B cells, plasma cells and long-lived memory B cells.
TLR7, a third signal for the robust generation H Fan et al major focus for therapy. 3 Given that GCs are important sites for B cells, how TLR7 regulates proliferation, the SMH and the antigen-based affinity selection of GC B cells needs to be further explored, and the results from these explorations will contribute to better therapies for GCrelated autoimmune diseases.
